Expert Review of Clinical Pharmacology（临床药理学专家评审杂志）影响因子_期刊投稿发表

期刊简介

Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery.Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.

药物开发技术的进步正在产生创新的新疗法，从可能挽救生命的药物到生活方式产品。然而，近年来，新药研发成本飙升，对耐药性和药物经济学的担忧凸显出来。在临床试验水平上发生的不良反应不断提醒严格的安全性和毒性试验的重要性。此外，药物基因组学和“个性化”治疗方法的出现将需要一种新的药物评估和医疗保健提供方法。临床药理学在整合所有专家和参与者的专业知识方面发挥着重要作用，这些专家和参与者积极应对现代生物医学实践中的挑战。

《Expert Review of Clinical Pharmacology》期刊已被查看：次

分区信息